Developing a value proposition for sustainable R&D and availability of Lassa fever therapeutics in West Africa by Wajeeha Malik | Jun 19, 2024
Ribavirin for treating Lassa fever: A systematic review of pre-clinical studies and implications for human dosing by Wajeeha Malik | Jun 19, 2024
Lack of Evidence for Ribavirin Treatment of Lassa Fever in Systematic Review of Published and Unpublished Studies by Eamonn | May 3, 2024
Final Report – Analysis of a Clinical Trial: Ribavirin and The Treatment Of Lassa Fever by Wajeeha Malik | Apr 24, 2024This is a copy of the Report Analysis of a Clinical Trial for Ribavirin and the Treatment of Lassa Fever. The data were collected by the US Centers for Disease Control under their IND 17186.
